Role of iron in neurodegenerative diseases and aging

被引:0
|
作者
Smith, MA
Sayre, LM
Perry, G
机构
[1] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:S5 / S5
页数:1
相关论文
共 50 条
  • [41] Iron chelation in the treatment of neurodegenerative diseases
    Dusek, Petr
    Schneider, Susanne A.
    Aaseth, Jan
    JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2016, 38 : 81 - 92
  • [42] Iron chelation and neuroprotection in neurodegenerative diseases
    Xuping Li
    Joseph Jankovic
    Weidong Le
    Journal of Neural Transmission, 2011, 118 : 473 - 477
  • [43] Mitochondrial iron metabolism and neurodegenerative diseases
    Cheng, Ruiying
    Dhorajia, Varun V.
    Kim, Jonghan
    Kim, Yuho
    NEUROTOXICOLOGY, 2022, 88 : 88 - 101
  • [44] Role of connexins in neurodegenerative diseases
    Xing, Juping
    Xu, Changshui
    MOLECULAR MEDICINE REPORTS, 2021, 23 (05)
  • [45] THE ROLE OF CLEARANCE IN NEURODEGENERATIVE DISEASES
    Brennan, Georgia s.
    Thompson, Travis b.
    Oliveri, Hadrien
    Rognes, Marie e.
    Goriely, Alain
    SIAM JOURNAL ON APPLIED MATHEMATICS, 2024, 84 (03) : S172 - S198
  • [46] The role of ferroptosis in neurodegenerative diseases
    Fei, Yifan
    Ding, Yifei
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2024, 18
  • [47] Role of Neddylation in Neurodegenerative Diseases
    Govindarajulu, Manoj
    Ramesh, Sindhu
    Shankar, Tharanth
    Kora, Murali Krishna
    Moore, Timothy
    Dhanasekaran, Muralikrishnan
    Gallart-Palau, Xavier
    NEUROSCI, 2022, 3 (04): : 533 - 545
  • [48] The role of α-synuclein in neurodegenerative diseases
    Bennett, MC
    PHARMACOLOGY & THERAPEUTICS, 2005, 105 (03) : 311 - 331
  • [49] Role of inflammation in neurodegenerative diseases
    Minghetti, L
    CURRENT OPINION IN NEUROLOGY, 2005, 18 (03) : 315 - 321
  • [50] The role of cannabinoids in neurodegenerative diseases
    Glass, M
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2001, 25 (04): : 743 - 765